What adverse effects can Remicade (infliximab) cause?
Remicade can cause side effects that range from mild infusion reactions to serious infections and other immune-related problems. The main categories patients ask about are:
Infusion or allergic-type reactions
These may happen during or shortly after an infusion and can include fever, chills, rash, itching, difficulty breathing, or changes in blood pressure. Serious reactions require urgent medical attention.
Increased risk of serious infections
Because infliximab suppresses parts of the immune system, it can increase the chance of infections, including infections that can become life-threatening. Patients are typically screened for prior tuberculosis and hepatitis before starting therapy.
Effects related to the immune system and blood counts
Some people develop problems such as low blood cell counts or other immune-related effects. These can show up as unusual bruising or bleeding, persistent fever, or severe fatigue, and need prompt evaluation.
Liver and other organ effects
Remicade can affect the liver in some patients. Symptoms that may prompt evaluation include yellowing of the skin/eyes, dark urine, or right upper abdominal pain.
Neurologic symptoms
Rarely, patients can experience neurologic problems (for example, symptoms resembling demyelinating disorders). New or worsening neurologic symptoms should be reported right away.
Who is at higher risk for Remicade adverse effects?
Risk is higher for people with factors such as:
- A history of chronic or recurrent infections
- Untreated or latent infections (especially tuberculosis or hepatitis)
- Prior serious reactions to biologic therapies
- Conditions that already affect the immune system
Age and other medications (particularly other immune-suppressing drugs) can also influence infection risk.
What side effects should be treated as emergencies?
Seek urgent care if symptoms suggest a severe allergic reaction or serious infection, such as:
- Trouble breathing, swelling of the face or throat, or widespread hives
- High fever, chills, or symptoms of rapidly worsening infection
- Severe weakness, confusion, or fainting
- Yellow skin/eyes or severe abdominal pain
What do patients typically experience most often?
Commonly reported adverse effects for infliximab products often include things like infusion-related symptoms (such as headache, dizziness, fever, or rash) and general reactions around the time of dosing. Frequency and severity vary by individual and dose schedule.
How do doctors monitor Remicade to catch problems early?
Clinicians generally manage risk with:
- Pre-treatment screening for infections (especially tuberculosis and hepatitis)
- Ongoing monitoring during treatment for infection signs and other adverse events
- Periodic lab work when indicated (for example, to watch blood counts and liver-related markers)
Can Remicade be stopped or switched if side effects happen?
If a patient develops a serious adverse effect, clinicians may stop Remicade and switch to another therapy depending on the cause and severity. The right next step depends on whether the event was an infusion reaction, infection, liver problem, blood count issue, or something else.
Are there other infliximab brands or biosimilars with the same type of risks?
Infliximab medicines (including biosimilars) share the same underlying mechanism and class warnings, so the adverse-effect categories overlap. Which option is appropriate depends on the patient’s history, access, and clinician judgment.
If you’re researching safety or patents, where can you check?
For background on infliximab products, including related commercial and patent landscape information, DrugPatentWatch.com can be a useful reference: https://www.drugpatentwatch.com/
---
Sources
DrugPatentWatch.com: https://www.drugpatentwatch.com/